Granted Patent
Utility
US 5,196,330 · App. 07/710,040
Type II restriction endonuclease, Pme I, obtainable from Pseudomonas mendocina and a process for producing the same
Inventors:
Richard D. Morgan, Bing Zhou
Patented Case
View Patent ↗
Granted: Mar 23, 1993
Filed: Jun 3, 1991
Inventors
Richard D. Morgan
Bing Zhou
Assignee (at issue)
New England Biolabs, Inc.
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.